Loading clinical trials...
Loading clinical trials...
Effect of Long-acting Somatostatin on Liver in Autosomal Dominant Polycystic Kidney Disease
Conditions
Interventions
octeotride
placebo
Start Date
January 1, 2009
Primary Completion Date
September 1, 2013
Last Updated
April 21, 2014
NCT07454174
NCT06065852
NCT03901521
NCT06594367
NCT06289998
NCT05190744
Lead Sponsor
Federico II University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions